A variety of oligopeptides have been localized in the nervous system. Some of these neuropeptides appear to play a role in the perception of pain and also may mediate analgesic mechanisms. Basic and clinical neuroscience relevant to these neuromodulators is reviewed.
HughesJ.SmithT.W.KosterlitzH.., Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature258: 577–579, 1975.
2.
KosterlitzH., and McKnightA.T.: Endorphins and enkephalins. Adv. Int. Med. 26: 1–36, 1980.
3.
MeitesJ.BruniJ.F.VanVugtD.A.., Relation of endogenous opioid peptides and morphine to neuroendocrine functions. Life Sci.24: 1325–1336, 1979.
4.
PertC.B.PasternakG., and SnyderS.H.: Opiate agonists and antagonists discriminated by receptor binding in brain. Science 182: 1359–1361, 1973.
5.
SimonE.J.HillerJ.M., and EdelmanI.: Stereospecific binding of the potent narcotic analgesic etorphine to rat-brain homogenate. Proc. Natl. Acad. Sci. USA 70: 1947–1949, 1973.
6.
TereniusL.: Characteristics of the ‘receptor’ for narcotic analgesics and a synaptic plasma membrane fraction from rat brain. Acta. Pharmacol. Toxicol. 33: 377–384, 1973.
7.
CreeseI., and SnyderS.H.: Receptor binding and pharmacological activity of opiates in the guinea pig intestine. J. Pharm. Exp. Therap. 194: 205–219, 1975.
8.
HillerJ.M.PearsonJ., and SimonE.J.: Distribution of stereo-specific binding of the potent narcotic analgesic etorphine in the human brain: predominance in the limbic system. Res. Common. Chern. Pathol. Pharmacol. 6: 1052–1062, 1973.
9.
KuharM.J.PertC.B., and SnyderS.H.: Regional distribution of opiate receptor binding in monkey and human brain. Nature 245: 477–450, 1973.
10.
PertC.B.KuharM.J., and SnyderS.H.: Autoradiographic localization of the opiate receptor in rat brain. Life Sci. 16: 1849–1854, 1975.
11.
AtwehS.F., and KuharM.J.: Autoradiographic localization of opiate receptors in rat brain. I. spinal cord and lower medulla. Brain Res. 124: 53–67, 1977.
12.
PertC.B.AphoshianD., and SnyderS.H.: Phylogenetic distribution of opiate receptor binding. Brain Res. 75: 356–361, 1974.
13.
HutchinsonM.KosterlitzH.W.LeslieF.M.., Assessment in the guinea-pig ileum and mouse vas deferens of Eenzomorphans which have strong antinociceptive activity but do not substitute for morphine in the dependent monkey. Brit. J. Phaimacol. 55:541–546, 1975.
14.
MartinW.R.EadesC.G.ThompsonJ.A.., The effects of morphine- and nalorphine-like drugs in the non-dependent and morphine dependent chronic spinal dog. J. Pharmacol. Exp. Ther.197: 517–532, 1976.
15.
BradburyA.F.SmythD.G.SnellC.R.., C-fragment of lipotropin has a high affinity for brain opiate receptors. Nature260: 793–795, 1976.
16.
LazarusL.H.LingN., and GuilleminR.: B-lipotropin as a prohormone for the morphinomimetic peptides, endorphins and enkephalins. Proc. Natl. Acad. Sci. USA 73: 2156–2159, 1976.
17.
LiC., and ChungD.: Isolation and structure of an untriakontapeptide with opiate activity from camel pituitary glands. Proc. Natl. Acad. Sci. USA 73: 1145–1148, 1976.
18.
GuilleminR.VargoT.RossierJ.., B-endorphin and -adrenocorticotropin are secreted concommitantly by the pituitary gland. Science197: 1367–1368, 1977.
19.
EideR.HokfeltT.JohanssonO., ., Immunohistochemical studies using antibodies to leu-enkephalin: initial observations on the nervous system of the rat. Neuroscience1: 349–351, 1976.
20.
HughesJ.KosterlitzH.W., and SnithT.W.: The distribution of methionine-enkephalin and leucine-enkephalin in the brain and peripheral tissues. Br. J. Pharmacol. 61: 637–648, 1977.
21.
SimantovR.KuharM.J.UhlG.R.., Opioid peptide enkephalin: immunohistochemical mapping in rat central nervous system. Proc. Natl. Acad. Sci. USA74: 2167–2171, 1977.
22.
WatsonS.AkilH.SullivanS.., Immunocytochemical localization of met-enkephalin: preliminary observations. Life Sci.21: 733–738, 1977.
23.
BloomF.BattenbergE.RossierJ.., Neurons containing B-endorphin in rat brain exist separately from those containing enkephalin: immunocytochemical studies. Proc. Natl. Acad. Sci. USA75: 1591–1595, 1978.
24.
WatsonS.J.AkilH.RichardC.W.., Evidence for two separate opiate peptide neuronal systems. Nature275: 226–228, 1978.
25.
KobayashiR.M.PalkovitsM.MillerR.J.., Brain enkephalin distribution is unaltered by hypophysectomy. Life Sci.22: 527–530, 1977.
26.
SimantovR.ChildersS.R., and SnyderS.H.: Opioid peptides: differentiation by radioimmunoassay and radioreceptor assay. Brain Res. 135: 358–367, 1977.
27.
HokfeltT.LjungdahlA.TereniusL.., Immunohistochemical analysis of peptide pathways possibly related to pain and analgesia: enkephalin and substance P. Proc. Natl. Acad. Sci. USA74: 3081–3085, 1977.
28.
SimantovR.SnowmanA., and SnyderS.H.: A morphine-like factor ‘enkephalin’ in rat brain: subcellular localization. Brain Res. 107: 650–657, 1976.
29.
HendersonG.HughesJ., and KosterlitzH.W.: In vitro release of leu- and met-enkephalin from the corpus striatum. Nature 271: 677–679, 1978.
30.
ZieglgansbergerW., and BayerlH.: The mechanism of inhibition of neuronal activity by opiates in the spinal cord of cat. Brain Res. 115: 111–128, 1976.
31.
DugganA.W.HallJ.G., and HeadleyP.M.: Enkephalins and dorsal horn neurones of the cat: effect on responses to noxious and innocuous skin stimuli. Br. J. Pharmacol. 61: 399, 1977.
32.
CrainS.M.CrainB.PetersonL.R.., Selective depression by opioid peptides of sensory-evoked dorsalTom network responses in organized spinal cord cultures. Brain Res.157: 196–201, 1978.
33.
FredericksonR., and NorrisF.H.: Enkephalin-induced depression of single neurons in brain areas with opiate receptors-antagonism by naloxone. Science 194: 440–42, 1976.
34.
NicollR.A.SigginsG.R.LingN.: Neuronal actions of endorphins and enkephalins among brain regions: a comparative micro- iontophoretic study. Proc. Natl. Acad. Sci. USA74: 2584–2588, 1977.
35.
BasbaumA.I., and FieldsH.L.: Endogenous pain control mechanisms: review and hypothesis. Annals of Neurology 4: 451–462, 1978.
36.
FieldsH.L., and BasbaumA.I.: Brainstem control of spinal pain-transmission neurons. Ann. Rev. Physiol. 40: 217–248, 1978.
37.
LohH.H.TsengL.F.WeiE.: B-endorphin is a potent analgesic agent. Proc. Natl. Acad. Sci. USA73: 2895–2898, 1976.
38.
FeldbergW., and SmythD.G.: The C-fragment of lipotropin- a potent analgesic. J. Physiol. 260: 30P-31P, 1976.
39.
BeluzziJ.D.GrantN.GarskyV.: Analgesia induced in vivo by central administration of enkephalin in rat. Nature260: 625–261976.
40.
ChangJ.-K.FongB.T.W.PertA.: Opiate receptor affinities and behavioral effects of enkephalin: structure activity relationship of ten synthetic peptide analogues. Life Sci.18: 1473–81, 1976.
41.
PertC.B.PertA.ChangJ.K.: (D-Ala2)-met-enkephalinamide: a potent, long lasting synthetic pentapeptide analgesic. Science194: 330–32, 1976.
42.
FoleyK.M.KouridesI.A.InturrisK.E.: B-endorphin: analgesic and hormonal effects in humans. Proc. Natl. Acad Sci. USA76: 5377–81, 1979.
43.
OyamaT.JinT.YamayaR.: Profound analgesic effects of B-endorphin in man. Lancet, 122–24, 1980.
44.
HosobuchiY., and LiC.H.: Demonstration of the analgesic activity of human B-endorphin in 6 patients. InUsdinE., BunneyW.E., and KlineN.S. (eds).: Endorphins in Mental Health Research, Oxford University Press, pps. 529–34, 1979
45.
AkilH.MayerD.J., and LiebeskindJ.C.: Antagonism of stimulation- produced analgesia by naloxone, a narcotic antagonist. Science 191: 961–62, 1976.
46.
HosobuchiY.AdamsJ.E., and LinchitzR.: Pain relief by electrical stimulation of the central gray matter in humans and its reversal by naloxone. Science 197: 183–86, 1977.
47.
AkilH.RichardsonD.E.BarchasJ.D.: Appearance of B-endorphin-like immunoreactivity in human ventricular cerebrospinal fluid upon analgesic electrical stimulation. Proc. Natl. Acad. Sci. USA75: 5170–72, 1978.
48.
SalarG.JobI.MigrinoS.: Effect of transcutaneous electro-therapy on CSF B-endorphin content in patients without pain problems. Pain10: 169–72, 1981.
49.
PomeranzB., and ChiuD.: Naloxone blockade of acupuncture analgesia: endorphin implicated. Life Sci. 19: 1757–62, 1976.
50.
MayerD.J.PriceD.D., and RafiiA.: Antagonism of acupuncture analgesia in man by the narcotic antagonist naloxone. Brain Res. 121: 368–72, 1977.
51.
SjolundB.TereniusL., and ErikssonM.: Increased CSF levels of endorphins after electroacupuncture. Acta. Physiol. Scand. 100: 382–84, 1977.
52.
QnuraY.: Pain threshold measurement before and after acupuncture: Controversial results of radiant heat method and electrical method and the roles of ACTH-like substances and endorphins. Acupuncture and Electro-Therapeut. Res. Int. J. 3: 1–21, 1978.
53.
QnuraY.PartII. Impressions of the history making acupuncture symposia held in Peking and travel experiences in the People's Republic of China. Acupuncture and Electro-Therapeut. Res. Int. J.5: 1–28, 1980.
54.
AlmayB.JohanssonF.KnorringL.V.: Endorphins in chronic pain. I. Differences in CSF endorphin levels between organic and psychogenic pain syndromes. Pain5: 153–62, 1978.
55.
VonKnorringL.AlmayB.JohanssonF.: Pain perception and endorphin levels in CSF. Pain5: 359–62, 1978
56.
DehenJ.WillerJ.C.BoureauF.: Congenital insensitivity to pain and endogenous morphine-like substances. Lancet2: 293–4, 1977.
57.
El-SobkyA.DostrovskyJ.O., and WallP.D.: Lack of effect of naloxone on pain perception in humans. Nature 263: 783–84, 1976.
58.
BuschsbaumM.E.DavisG.C., and BunneyW.E.: Naloxone alters pain perception and somatosensory evoked potentials in normal subjects. Nature 270: 620–22, 1977.
59.
LindblomU., and TegnerR.: Are the endorphins active in clinical pain states? Narcotic antagonism in chronic pain patients. Pain 7: 65–69, 1979.
60.
LevineJ.D.GordonN.G.BornsteinN.: Role of pain in placebo analgesia. Proc. Natl. Acad. Sci. USA76: 3528–31, 1979.
TsengL.F.LohH.H., and LiC.H.: B-endorphin: cross tolerance and cross-physical dependence on morphine. Proc. Natl. Acad. Sci. USA 73: 4187–89, 1976.
63.
WeiE., and LohH.H.: Physical dependence on opiate-like peptides. Science 193: 1262–63, 1976.
64.
GoldsteinA.S.TachibanaL.I.LowneyM.: Dynorphin (1-13), an extraordinarily potent opioid peptide. Proc. Natl. Acad. Sci. USA76: 6666–69, 1979.
65.
FriedmanH.J.JenM.F.ChangJ.K.: Dynorphin: A possible modulatory peptide on morphine or B-endorphin analgesia in mouse. Eur. J. Pharmacol.69: 357–60, 1981.
66.
KangawaK.MatsuoH., and IgaraihiM.: α-neo-endorphin: A“big” leu-enkephalin with potent opiate activity from porcine hypothalami. Biochem. Biophys. Res. Comm. 86: 153–60, 1979.
67.
Euler von, U.S., and J.Gaddum: An unidentified depressor substance in certain tissue extracts. J. Physiol. (Lond.) 72: 74–81, 1931.
68.
ChangM.M., and LeemanS.E.: Isolation of a sialogogic peptide from bovine hypothalamic tissue and its characterization as substance P. J. Biol. Chem. 245: 4784–90, 1970.
69.
HokfeltT.KellerethJ.O.NilssonG.: Experimental immunohistochemical studies on the localization and distribution of SP in cat primary sensory neurons. Brain Res.100: 235–52, 1975.
70.
CuelloA.C., and KanatawaI.: The distribution of substance P immuno-reactive fibers in the rat central nervous system. J. Comp. Neurol. 178: 129–56, 1978.
71.
LjungdahlA.HokfeltT., and NilssonG.: Distribution of SP-like immunoreactivity in the central nervous system of the rat. I cell bodies and nerve terminals. Neuroscience 3: 227–68, 1980.
72.
NicollR.A.SchenkerC., and LeemanS.E.: Substance P as a transmitter candidate. Ann. Rev. Neurosci. 3: 227–68, 1980.
73.
HokfeltT.EideR.JohanssonO.: Immunohistochemical evidence for separate populations of somatostatin-containing and substance P- containing primary afferent neurons in the rat. Neurosci.1: 131–36, 1976.
74.
HokfeltT.JohanssonO., KellerterJ.O., : Immunohistochemical distribution of SP. In Substance P U.S. von Euler and B. Pemow (eds.). pps. 117–145, Raven, N.Y., 1977.
75.
TakahashiT., and OtsukaM.: Regional distribution of substance P in the spinal cord and nerve roots of the cat and the effect of dorsal root section. Brain Res. 87: 1–11, 1975.
76.
CuelloA.C.DelFiaccoM., and PaxinosG.: The central and peripheral ends of the substance P-containing sensory neurons in the rat trigeminal system. Brain Res. 152: 499–502, 1978.
77.
JessellT.TsunoO.A.KanatawaI.: SubstanceP: Depletion in the dorsal horn of the rat spinal cord alter section of the peripheral processes of primary sensory neurons. Brain Res. 168: 247–60, 1979.
78.
HenryJ.H.: Effects of substance P on functionally identified units in cat spinal cord. Brain Res. 114: 439–52, 1976.
79.
RandicM., and MileticU.: Effect of substance P in cat dorsal horn neurons activated by noxious stimuli. Brain Res. 128: 164–69, 1977.
80.
AndersenR.K.LundJ.P., and PuiliE.: Enkephalin and substance P effects related to trigeminal pain. Can. J. Physiol. Pharmacol. 56: 164–169, 1977.
81.
MudgeA.W.LeemanS.E., and FischbachG.: Enkephalin inhibits release of substance P from sensory neurons in culture and decreases action potential duration. Proc. Natl. Acad. Sci. USA 76: 526–30, 1979.
82.
JessellT.M., and IversenL.L.: Opiate analgesics inhibit substance P release from rat trigeminal nucleus. Nature 268: 550–52, 1977.
83.
LaMotteC.PertC.B., and SnyderS.H.: Opiate receptor binding in primate spinal cord: distribution and changes after dorsal root section. Brain Res. 112: 407–421, 1976.
84.
OlgartL.UateliusB.BrodinE.: Release of SP-like immuno-reactivity from the dental pulp. Acta. Physiol. Scand.101: 510–512, 1977.
85.
OlgartL.HokfeltT.NilssonG.: Localization of substance P-like immunoreactivity in nerves in the tooth pulp. Pain4: 153–59, 1977.
86.
VirusR.M., and GebhartG.F.: Pharmacologic actions of capsaicin: Apparent involvement of substance P and serotonin. Life Sci. 25: 1273–84, 1979.
87.
PorszaszJ., and JancsoN.: Studies on the action potentials of sensory nerves in animals desensitized with capsaicin. Acta. Physiol. (Hung.) 16: 299–306, 1959.
88.
ThenaultE.OtsukoM., and JessellT.: Capsaicin-evoked release of substance P from primary sensory neurons. Brain Res. 170: 209–213, 1979.
89.
JessellT.M.Iver-enL.L., and CuelloA.C.: Capsaicin-induced depletion of substance P from primary sensory neurons. Brain Res. 152: 183–188, 1978.
90.
JancsoN.: Desensitization with capsaicin and related arylamides as a tool for studying the function of pain receptors. Proc. 3rd. Int. Pharmacol. Sao Paulo. In Pharmacology and Pain 9, 33–99. Oxford Pergmon 1969.
91.
YakshT.L.FarbD.H.LeemanS.: Intrathecal capsaicin depletes substance P in the rat spinal cord and produces prolonged thermal analgesia. Science206: 481–83, 1977.
92.
HayesA.G., and TyersM.B.: Effects of capsaicin on nociceptive, heat, pressure and chemical thresholds and on substance P levels in the rat. Brain Res. 189: 561–64, 1980.
93.
GamseR.LacknerD.GamseG.: Effect of capsaicin pretreatment on capsaicin-evoked release of immunoreactive somatostatin and substance P from primary sensory neurons. Naunyn-Schmiedeberg's Arch. Pharmacol.316: 38–41, 1981.
94.
KesslerJ.A., and BlackI.B.: Similarities in development of substance P and somatostatin in peripheral sensory neurons: Effects of capsaicin and nerve growth factor. Proc. Natl. Acad. Sci. USA 78: 4644–47, 1981.
95.
AinsworthA.HallP.AutG.: Effects of capsaicin applied locally to adult peripheral nerve. II-Anatomy and enzyme and peptide chemistry of peripheral nerve and spinal cord. Pain11: 379–388, 1981.
96.
StewartJ.M.GettoC.J., and NeldnonK.: Substance P and analgesia. Nature262: 784–85, 1976.
97.
HayesA.G., and TyersM.B.: Effects of intrathecal and intracerebro- ventricular injections of substance P on nociception in the rat and mouse. Br. J. Pharmacol. 66: 488P, 1979.
98.
MohrlandJ.S., and GebhartG.F.: Substance P-induced analgesia in the rat. Brain Res. 171: 556–59, 1979.
99.
OehmeP.HilseH.MorgensteinE.: SubstanceP: Does it produce analgesia or hyperalgesia? Science 208: 305–307, 1980.
100.
FredericksonR.BurgisV.HarrellC.E.: Dual actions of substance P on nociception: possible role of endogenous opioids. Science199: 1359–62, 1978.
101.
Chan-PalayV., and PalayS.L.: Ultrastructural identification of substance P cells and their processes in rat sensory ganglia and their terminals in the spinal cord by immunocytochemistry. Proc. Natl. Acad. Sci. USA 74: 4050–54, 1977.
102.
Chan-PalayV.JonssonG., and PalayS.L.: Serotonin and substance P coexist in rat central nervous system. Proc. Natl. Acad. Sci. USA 75: 1582–86, 1978.
103.
HokfeltT.LjungdahlA.SteinbuschH.: Immunohistochemical evidence of substance P-like immunoreactivity in some 5-HT-containing neurons in rat central nervous system. Neuroscience3: 517–538, 1978.
104.
PelletierG.SteinbuschH., and VeshofstadA.A.: Immunoreactive substance P and serotonin present in the same dense core vesicles. Nature 293: 71–72, 1981.
105.
PhillisJ.W.: Is B (4-chlorophenyl) -GABA a specific antagonist of substance P on cerebral cortical neurons? Experientia 32: 593, 1976.
106.
EngbergG.SvenssenT.ResellS.: A synthetic peptide as an antagonist of substance P. Nature293: 222–23, 1981.
107.
WallP.D.FitzgeraldM., and GibsonS.J.: The response of rat spinal cord cells to unmyelinated afferents after peripheral nerve section and after changes in substance P levels. Neuroscience 6: 2205–2215, 1981.
108.
ClineschmidtB., and McGuffinJ.: Neurotensin administered intra- cistemally inhibits responsiveness of mice to noxious stimuli. Eur. J. Pharmacol. 46: 395–96, 1977.
109.
NemeroffC.B.OsgahrA.T.ManbergP.J.: Alterations in nociception and body temperature after intracisteral administration of neurotensin, B-endorphin, other endogenous peptides and morphine. Proc. Natl. Acad. Sci. USA76: 5368–71, 1979.
110.
OsbahrA.J.NemeroffC.B.LuttingerD.: Neurotensin-induced antinociception in mice: Antagonism by thyrotropin-releasing hormone. J. Pharmacol. Exp. Therapeutics217: 645–651, 1981.
111.
UhlG.R.KuharM.J., and SnyderS.H.: Neurotensin: Immunohistochemical localization in rat central nervous system. Proc. Natl. Acad. Sci. USA 74: 4059–4063, 1977.
112.
UhlG.R.GoodmanR.R., and SnyderS.H.: Neurotensin-containing cell bodies, fibers and nerve terminals in the brainstem of the rat: Immunohistochemical mapping. Brain Res. 167: 77–91, 1979.
113.
KahnD.AbramsG.M.ZimmermanE.A.: Neurotensin neurons in the rat hypothalamus: An immunocytochemical study. Endocrinology107: 47–54, 1980.
114.
YoungW.SocttG., and KuharM.: Neurotensin receptor localization by light microscopic autoradiography in rat brain. Brain Res. 206: 273–285, 1981.
115.
YoungW.UhlG., and KuharM.: Iontophoresis of neurotensin in the area of the locus coeruleus. Brain Res. 150: 431–35, 1978.
116.
AghajanianG.K.: Tolerance of locus coeruleus neurons to morphine suppression of withdrawal responses by clonidine. Nature (Lond.) 286: 186–87, 1978.
117.
BrownM.RivierJ., and ValeW.: Bombesin: Potent effects on thermo-regulation in the rat. Science 196: 998–1000, 1977.
118.
GibbsJ.FauserD.J.RoweE.A.: Bombesin suppresses feeding in rats. Nature282: 208–210, 1979.
119.
AnastasiA.ErspamerV., and DucciM.: Isolation and structure of bombesin and Alytesin, two analogous active peptides from the skin of the European Amphibians, Bombina and Alytes. Experientia 27: 166–67, 1971.
120.
YamadaT.TakamiM., and GeroerR.: Bombesin-like immunoreactivity in human CSF. Brain Res. 223: 214–217, 1981.
121.
MoodyT.W.ThoaN.B.O'DonohueT.L.: Bombesin-like peptides in rat spinal cord: Biochemical characterization, localization, and mechanism of release. Life Sci.29: 2273–79, 1981.
122.
PertA.MoodyT.PertC.B.: Bombesin: Receptor distribution in brain and effects on nociception and locomotor activity. Brain Res.193: 209–220, 1980.
123.
SwansonL.W.: Immunohistochemcial evidence for a neurophysin-containing autonomic pathway arising in the paraventricular nucleus of the hypothalamus. Brain Res. 128: 346–353, 1977.
124.
NilaverG.HoffmanD.L., and ZimmermanE.A.: Multiple projections of the magnocellular hypothalamus to other brain regions including cerebral cortex. Trans. Amer. Neurological Assn. 104: 1–3, 1979.
125.
BemstonG.G., and BessonB.S.: Antinociceptive effects of intra-ventricular systemic administration of vasopressin in the rat. Life Sci. 26: 45S-59, 1980.
126.
BodnarR.J.ZimmermanE.A.NilaverG.: Dissociation of cold-water swim and morphine analgesia in Brattleboro rats with diabetes insipidus. Life Sci.26: 1581–1590, 1980.
127.
SnyderS.H. Peptide neurotransmitters with possible involvements in pain perception. In Bonica JJ (ed.), Pain, Raven Press, N.Y., 1980.
128.
CorreaF.M.InnisR.B.UhlG.R.: Bradykinin-like immuno-reactive neuronal systems localized histochemically in rat brain. Proc. Natl. Acad. Sci. USA76: 489–493, 1979.
129.
FerreiraS.H.: Prostaglandins, aspirin-like drugs and analgesia. Nature (New Biology) 240: 200–203, 1972.
130.
RandicM., and MileticV.: Depressant actions of methionine-enkephalin and somatostatin in cat dorsal horn neurons activated by noxious stimuli. Brain Res. 152: 196–202, 1978.
131.
LundbergJ.M.HokfeltT.NilssonG.: Peptide neurons in the vagus, splanchnic and sciatic nerves. Acta. Physiol. Scand.104: 499–501, 1978.
132.
InnisR.B.CorreaF.M.UhlG.: Cholecystokinin octapeptide- like immunoreactivity: Histochemical localization in rat brain. Proc. Natl. Acad. Sci. USA76: 521–25, 1979.
133.
ZarbinM.A.InnisR.B.WamselyJ.K.: Autoradiographic localization of CCK receptors in guinea pig brain. Eur. J. Pharmacol.71: 349–350, 1981.
134.
ZetlerG.Analgesia and ptosis caused by caerulein and cholecystokinin octapeptide. Neuropharmacology19: 415–422, 1980.
135.
GantenD.FuxeK.PhillipsM.I.: The brain isorenin-angiotensin system: Biochemistry, localization and possible role in drinking and blood pressure regulation. In W.F. Ganong and L. Martini (eds.), Frontiers in Neuroendocrinology 5, pps.61–100, Raven Press, N.Y., 1978.
136.
BhargaraH.N., and MatwyshynG.A.: Influence of thyrotropin-releasing hormone and histidyl-proline dilcetopiperazine on spontaneous locomotor activity and analgesia induced by D9-tetrahydrocannabinol in the mouse. Eur. J. Pharmacol. 68: 147–154, 1980.
